Israel
Ambrosia Bio, founded in 2020 and headquartered in Israel, is making noteworthy strides in the Biotechnology, Food and Beverage, and Nutrition industries.
Their slogan, "We are forging a healthier world, one rare sugar at a time," reflects their mission to revolutionize sugar consumption. Utilizing a disruptive enzyme technology platform, Ambrosia Bio designs superior enzymes that convert high-calorie industrial sugars into rare, minimal-calorie sugars. This capability addresses the growing consumer demand for sugar reduction while preserving taste, positioning them as an attractive partner to major sugar and juice manufacturers.
Their B2B model focuses on delivering tailored plug-and-play engineering solutions to meet the rising demand for Allulose. Their latest financial backing, an unknown investment from Space-F on 01 March 2023, underscores investor confidence in their technology and market potential, further strengthening their market position.
